| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Michael D Kleinhenz, Geraldine Magnin, Zhoumeng Lin, Jason Griffin, Katie E Kleinhenz, Shawnee Montgomery, Andrew Curtis, Miriam Martin, Johann F Coetze. Plasma concentrations of eleven cannabinoids in cattle following oral administration of industrial hemp (Cannabis sativa). Scientific reports. vol 10. issue 1. 2021-01-13. PMID:32728233. |
plasma concentrations of eleven cannabinoids in cattle following oral administration of industrial hemp (cannabis sativa). |
2021-01-13 |
2023-08-13 |
cattle |
| Amir Garakani, James W Murrough, Rafael C Freire, Robyn P Thom, Kaitlyn Larkin, Frank D Buono, Dan V Iosifesc. Pharmacotherapy of Anxiety Disorders: Current and Emerging Treatment Options. Frontiers in psychiatry. vol 11. 2021-01-12. PMID:33424664. |
although there are some recent randomized controlled trials for novel agents including neuropeptides, glutamatergic agents (such as ketamine and d-cycloserine), and cannabinoids (including cannabidiol) primarily in gad or sad, these trials have largely been negative, with only some promise for kava and ph94b (an inhaled neurosteroid). |
2021-01-12 |
2023-08-13 |
Not clear |
| Masahiko Funada, Mika Takebayashi-Ohsawa, Ken-Ich Tomiyam. Synthetic cannabinoids enhanced ethanol-induced motor impairments through reduction of central glutamate neurotransmission. Toxicology and applied pharmacology. vol 408. 2021-01-11. PMID:33068620. |
marijuana or synthetic cannabinoids and alcohol are often used together, with these combinations causing motor impairments that can subsequently lead to motor vehicle accidents. |
2021-01-11 |
2023-08-13 |
mouse |
| Hollis C Karoly, Raeghan L Mueller, Chrysta C Andrade, Kent E Hutchiso. Investigating Relationships Between Alcohol and Cannabis Use in an Online Survey of Cannabis Users: A Focus on Cannabinoid Content and Cannabis for Medical Purposes. Frontiers in psychiatry. vol 11. 2021-01-11. PMID:33408657. |
investigating relationships between alcohol and cannabis use in an online survey of cannabis users: a focus on cannabinoid content and cannabis for medical purposes. |
2021-01-11 |
2023-08-13 |
Not clear |
| Luca Massimin. F1000Research. vol 6. 2021-01-09. PMID:28529696. |
the cannabis plant and its active ingredients (i.e., cannabinoids and terpenoids) have been socially stigmatized for half a century. |
2021-01-09 |
2023-08-13 |
Not clear |
| Chandni Hindocha, Tom P Freeman, Meryem Grabski, Jack B Stroud, Holly Crudgington, Alan C Davies, Ravi K Das, William Lawn, Celia J A Morgan, H Valerie Curra. Cannabidiol reverses attentional bias to cigarette cues in a human experimental model of tobacco withdrawal. Addiction (Abingdon, England). 2021-01-09. PMID:29714034. |
cannabidiol (cbd), a non-intoxicating cannabinoid found in cannabis, may be a promising novel smoking cessation treatment due to its anxiolytic properties, minimal side effects and research showing that it may modify drug cue salience. |
2021-01-09 |
2023-08-13 |
human |
| Andrew F Scheyer, Milene Borsoi, Jim Wager-Miller, Anne-Laure Pelissier-Alicot, Michelle N Murphy, Ken Mackie, Olivier J J Manzon. Cannabinoid Exposure via Lactation in Rats Disrupts Perinatal Programming of the Gamma-Aminobutyric Acid Trajectory and Select Early-Life Behaviors. Biological psychiatry. vol 87. issue 7. 2021-01-06. PMID:31653479. |
cannabis use by mothers during lactation transfers active cannabinoids to the developing offspring during this critical period and alters postnatal neurodevelopment. |
2021-01-06 |
2023-08-13 |
rat |
| Zaid H Maayah, Shingo Takahara, Mourad Ferdaoussi, Jason R B Dyc. The molecular mechanisms that underpin the biological benefits of full-spectrum cannabis extract in the treatment of neuropathic pain and inflammation. Biochimica et biophysica acta. Molecular basis of disease. vol 1866. issue 7. 2021-01-05. PMID:32201189. |
the biological effect of cannabis is mainly attributed to two major cannabinoids, tetrahydrocannabinol and cannabidiol. |
2021-01-05 |
2023-08-13 |
Not clear |
| Zaid H Maayah, Shingo Takahara, Mourad Ferdaoussi, Jason R B Dyc. The molecular mechanisms that underpin the biological benefits of full-spectrum cannabis extract in the treatment of neuropathic pain and inflammation. Biochimica et biophysica acta. Molecular basis of disease. vol 1866. issue 7. 2021-01-05. PMID:32201189. |
given that cannabis is known to generate a large number of cannabinoids along with numerous other biologically relevant products including terpenes, studies involving purified tetrahydrocannabinol and/or cannabidiol do not consider the potential biological benefits of the full-spectrum cannabis extracts. |
2021-01-05 |
2023-08-13 |
Not clear |
| Christopher M Jones, Heather B Clayton, Nicholas P Deputy, Douglas R Roehler, Jean Y Ko, Marissa B Esser, Kathryn A Brookmeyer, Marci Feldman Hert. Prescription Opioid Misuse and Use of Alcohol and Other Substances Among High School Students - Youth Risk Behavior Survey, United States, 2019. MMWR supplements. vol 69. issue 1. 2021-01-05. PMID:32817608. |
lifetime use of synthetic marijuana (also called synthetic cannabinoids) decreased during 2015-2019. |
2021-01-05 |
2023-08-13 |
Not clear |
| Reilly R Kayser, Margaret Haney, Marissa Raskin, Caroline Arout, Helen Blair Simpso. Acute effects of cannabinoids on symptoms of obsessive-compulsive disorder: A human laboratory study. Depression and anxiety. vol 37. issue 8. 2020-12-31. PMID:32383271. |
preclinical data implicate the endocannabinoid system in the pathology underlying obsessive-compulsive disorder (ocd), while survey data have linked ocd symptoms to increased cannabis use. |
2020-12-31 |
2023-08-13 |
human |
| Aurora Musa, Nicola Simola, Gessica Piras, Francesca Caria, Emmanuel Shan Onaivi, Maria Antonietta De Luc. Neurochemical and Behavioral Characterization after Acute and Repeated Exposure to Novel Synthetic Cannabinoid Agonist 5-MDMB-PICA. Brain sciences. vol 10. issue 12. 2020-12-31. PMID:33353194. |
since the early 2000s, herbal mixtures containing synthetic cannabinoids (scs), broadly known as spice/k2, have been marketed as a legal marijuana surrogate and have become very popular among adolescents. |
2020-12-31 |
2023-08-13 |
mouse |
| Henry C Ezechukwu, Cornelius A Diya, Nirajan Shrestha, Deanne H Hryci. Role for endocannabinoids in early pregnancy: recent advances and the effects of cannabis use. American journal of physiology. Endocrinology and metabolism. vol 319. issue 3. 2020-12-30. PMID:32744098. |
alteration in cannabinoid receptor expression or in endocannabinoid homeostasis by excessive intake of cannabis during pregnancy is associated with negative pregnancy outcomes, including preterm birth. |
2020-12-30 |
2023-08-13 |
Not clear |
| Henry C Ezechukwu, Cornelius A Diya, Nirajan Shrestha, Deanne H Hryci. Role for endocannabinoids in early pregnancy: recent advances and the effects of cannabis use. American journal of physiology. Endocrinology and metabolism. vol 319. issue 3. 2020-12-30. PMID:32744098. |
cannabis contains phytocannabinoids, which modulate the ecs, and emerging evidence suggests that phytocannabinoids, through their action on cannabinoid receptors, may have a negative impact on fertility, pregnancy outcome, and fetal health. |
2020-12-30 |
2023-08-13 |
Not clear |
| Chanté Muller, Patricia H Reggi. An Analysis of the Putative CBD Binding Site in the Ionotropic Cannabinoid Receptors. Frontiers in cellular neuroscience. vol 14. 2020-12-29. PMID:33362478. |
a recently published cryo-em structure showed the putative binding location of a well-known cannabinoid ligand, cannabidiol (cbd), in trpv2, a channel that has been implicated in inflammation and chronic pain. |
2020-12-29 |
2023-08-13 |
Not clear |
| Erin M Rock, Megan T Sullivan, Stephen A Collins, Hannah Goodman, Cheryl L Limebeer, Raphael Mechoulam, Linda A Parke. Evaluation of repeated or acute treatment with cannabidiol (CBD), cannabidiolic acid (CBDA) or CBDA methyl ester (HU-580) on nausea and/or vomiting in rats and shrews. Psychopharmacology. vol 237. issue 9. 2020-12-23. PMID:32488349. |
when acutely administered intraperitoneally, the non-psychoactive cannabinoid cannabidiol (cbd), its acidic precursor cannabidiolic acid (cbda) and a stable methyl ester of cbda (hu-580) reduce lithium chloride (licl)-induced conditioned gaping in male rats (a selective preclinical model of acute nausea) via activation of the serotonin 1a (5-ht |
2020-12-23 |
2023-08-13 |
rat |
| Jonathan P Wenger, Clemon J Dabney, Mahmoud A ElSohly, Suman Chandra, Mohamed M Radwan, Chandrani G Majumdar, George D Weible. Validating a predictive model of cannabinoid inheritance with feral, clinical, and industrial Cannabis sativa. American journal of botany. vol 107. issue 10. 2020-12-23. PMID:33103246. |
validating a predictive model of cannabinoid inheritance with feral, clinical, and industrial cannabis sativa. |
2020-12-23 |
2023-08-13 |
Not clear |
| Wang Zhen, M I Yao-Lei, Meng Xiang-Xiao, Wan Hui-Hua, J I Ai-Jia, Sun Wei, M A We. [Genome-wide analysis of LBD(lateral organ boundaries domain) gene family in Cannabis sativa of traditional Chinese medicine hemp seed]. Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica. vol 45. issue 22. 2020-12-23. PMID:33350209. |
these genes may participate in the growth and development of cannabis and affect the biosynthesis of cannabinoids. |
2020-12-23 |
2023-08-13 |
Not clear |
| Benedikt Bernd Claus, Michael Specka, Heath McAnally, Norbert Scherbaum, Fabrizio Schifano, Udo Bonne. Is the Urine Cannabinoid Level Measured via a Commercial Point-of-Care Semiquantitative Immunoassay a Cannabis Withdrawal Syndrome Severity Predictor? Frontiers in psychiatry. vol 11. 2020-12-22. PMID:33343424. |
is the urine cannabinoid level measured via a commercial point-of-care semiquantitative immunoassay a cannabis withdrawal syndrome severity predictor? |
2020-12-22 |
2023-08-13 |
Not clear |
| Nilson Carlos Ferreira Junior, Maurício Dos-Santos-Pereira, Francisco Silveira Guimarães, Elaine Del Be. Cannabidiol and Cannabinoid Compounds as Potential Strategies for Treating Parkinson's Disease and L-DOPA-Induced Dyskinesia. Neurotoxicity research. vol 37. issue 1. 2020-12-21. PMID:31637586. |
cannabidiol and cannabinoid compounds as potential strategies for treating parkinson's disease and l-dopa-induced dyskinesia. |
2020-12-21 |
2023-08-13 |
Not clear |